Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

    NEXT STORY
    RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
    PREV STORY
    VitalFlow Reviews: Groundbreaking Report on VitalFlow for Prostate [Updated]
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AroCell presenterar resultat från U-CAN TK1 lymfomstudien samt från en studie där TK 210™ ELISA jämförs med andra metoder

    I samband med ISOBMs kongress (International Society of Oncology Biomarkers) i Hamburg, presenterar idag ...

    author_avatar
    NASDAQ Market News

    Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

    author_avatar
    NASDAQ Market News

    Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates

    author_avatar
    NASDAQ Market News